In this context, AFP [1, 11, 26–30] and PIVKA-II [26, 31] levels remain pivotal as readily obtainable biomarkers, with decades-long validation as accurate and reliable indicators in clinical practice, and continue to provide crucial insights into tumor recurrence and survival outcomes through simple and singular measurements. This evidence concerns the gene AFP and neoplasm.